NCT01174992 - A Study to Evaluate the Safety and Effectiveness of EVICEL as an Adjunct to Sutured Dural Repair | Biotech Hunter

Enrollment

139

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

September 30, 2011

Study Completion Date

October 31, 2011

Conditions

Dura Defects

Interventions

BIOLOGICAL

Evicel

EVICEL is a human plasma derived fibrin sealant

OTHER

Sutures only

Standard of care

Trial Locations (12)

Department of Neurosurgery, University Giessen-Marburg, Giessen

Department of Neurosurgery, Klinikum Ingolstadt GmbH, Ingolstadt

Department of Neurosurgery, Ziekenhuis Oost Limburg, Genk

Department of Neurosurgery, University Hospital of Liège, Liège

Department of Neurosciences and Rehabilitation, Tampere University Hospital, Tampere

Service de Neurochirurgie B, Hopital Neurologique de Lyon, Cedex

Klinik für Neurochirurgie, Universitätsklinikum Essen, Essen

Department of Neurosurgery University Clinics of Schleswig-Holstein Campus Kiel, Kiel

VU Medical Centre, Amsterdam

Department of Neurosurgery, John Radcliffe Hospital, Headington

Department of Neurosurgery, Ninewells Hospital & Medical School, Dundee

Edinburgh Centre for Neuro-Oncology, Western General Hospital, Edinburgh